Considering that all NMO/NMO-SD patients in the present study were AQP4-seropositive, it is tempting to speculate that the specifically increased Igs, including the IgG3 are in fact AQP4-antibodies but this could not be confirmed by immunoassays. This evidence concerns the gene IGHG3 and Salla disease.